Finance

Lists
NRX:CVE
Nurexone Biologic Inc
CA$0.64
0.00%
(0.00) 1D
Oct 1, 9:30:00 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NRX...
Mkt. cap
61.69M
Avg. vol.
27.72K
Volume
0.00
52-wk high
CA$1.09
52-wk low
CA$0.44
EPS
-CA$0.10
Beta
0.23
Shares outstanding
96.40M
No. of employees
9
Mkt. cap
61.69M
Avg. vol.
27.72K
Volume
0.00
52-wk high
CA$1.09
52-wk low
CA$0.44
EPS
-CA$0.10
Beta
0.23
Shares outstanding
96.40M
No. of employees
9
News stories
From web sources and news partners
About Nurexone Biologic Inc
CEO-
Employees9
Founded2011
Headquarters-
SectorBiotechnology
Websitenurexone.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
703.00K
619.00K
630.00K
748.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
763.00K
716.00K
1.13M
927.00K
Operating expense
1.47M
1.34M
1.76M
1.68M
Total operating expenses
1.47M
1.34M
1.76M
1.68M
Operating income
-1.47M
-1.34M
-1.76M
-1.68M
Other non operating income
-20.00K
5.00K
-6.00K
-6.00K
EBT including unusual items
-1.46M
-1.40M
-1.77M
-1.68M
EBT excluding unusual items
-1.46M
-1.40M
-1.77M
-1.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.46M
-1.40M
-1.77M
-1.68M
Net profit margin
-
-
-
-
Earnings per share
-0.02
-0.02
-0.02
-0.02
Interest and investment income
21.00K
27.00K
6.00K
13.00K
Interest expense
-
-43.00K
-9.00K
-15.00K
Net interest expenses
21.00K
-16.00K
-3.00K
-2.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.42M
-1.31M
-1.70M
-1.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps